https://doctransparency.com/doctor/tx/san-antonio/john-browning-1124181615
Medicare Enrolled

Dr. John Browning, MD

Pediatric Dermatology Physician · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
3320 OAKWELL CT, San Antonio, TX 78218
2108295180
In practice since 2006 (19 years)
NPI: 1124181615 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Browning from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Browning? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Browning

Dr. John Browning is a pediatric dermatology physician in San Antonio, TX, with 19 years in practice. Based on federal Medicare data, Dr. Browning performed 19,321 Medicare services across 4,101 unique beneficiaries.

Between the years covered by Open Payments, Dr. Browning received a total of $277,826 from 52 pharmaceutical and/or device companies across 1000 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric dermatology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Browning is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 9% volume in TX$ $277,826 industry payments

Medicare Practice Summary

Medicare Utilization ↗
19,321
Medicare services
Top 9% in TX for pediatric dermatology physician
4,101
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,017 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Photodynamic therapy gel for precancerous skin11,200$1$2
Destruction of precancerous skin growths, 2-142,909$5$25
Office visit, established patient (20-29 min)1,318$57$200
Destruction of precancerous skin growth, 1753$37$150
Skin biopsy, tangential480$63$249
New patient office visit (30-44 min)398$68$199
Destruction of skin growths (warts/lesions), 1-14381$77$200
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application320$91$150
Office visit, established patient (30-39 min)285$88$200
Superficial and/or low voltage radiation treatment delivery192$32$150
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area164$209$363
Biopsy of related skin growth, each additional growth153$39$249
Destruction of precancer skin growth, 15 or more growths127$126$446
New patient office visit (45-59 min)86$100$250
Office visit, established patient (10-19 min)86$35$200
Drug injection, under skin or into muscle83$9$65
Steroid injection (triamcinolone)52$1$5
Application of light to destroy precancer skin growth45$109$300
Biopsy of ear40$49$200
New patient office or other outpatient visit, 15-29 minutes36$43$200
Injection into skin growth, 1-7 growths28$31$100
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm26$121$320
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm24$217$450
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm22$325$800
Punch biopsy, first skin growth19$89$275
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm19$96$460
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm19$109$520
Destruction of skin growth, 15 or more growths16$90$250
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm14$147$400
Calculation of radiation therapy dose14$51$179
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm12$140$500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$277,826
Total received (2018-2024)
Avg $39,689/year across 7 years
Top 12% in TX for pediatric dermatology physician
52
Companies
1,000
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$203,747 (73.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$49,480 (17.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,598 (8.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$97,495
2023
$45,176
2022
$42,401
2021
$16,156
2020
$15,103
2019
$39,532
2018
$21,964

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$63,665
Regeneron Healthcare Solutions, Inc.
$53,938
Krystal Biotech Inc
$37,388
Dermavant Sciences, Inc.
$22,966
Galderma Laboratories, L.P.
$20,162
Pfizer Inc.
$12,830
Pierre Fabre Pharmaceuticals, Inc.
$11,550
Amryt Pharma Holdings Ltd
$9,853
GENZYME CORPORATION
$9,504
Novartis Pharmaceuticals Corporation
$7,647
DERMIRA, INC.
$5,160
Chiesi USA, Inc.
$3,880
Eli Lilly and Company
$3,649
LEO Pharma Inc.
$3,428
Verrica Pharmaceuticals Inc.
$3,051
ABBVIE INC.
$1,351
AbbVie Inc.
$1,140
AbbVie, Inc.
$1,056
Janssen Biotech, Inc.
$1,053
E.R. Squibb & Sons, L.L.C.
$669
Lilly USA, LLC
$659
Incyte Corporation
$329
Sun Pharmaceutical Industries Inc.
$327
Ortho Dermatologics, a division of Bausch Health US, LLC
$251
SUN PHARMACEUTICAL INDUSTRIES INC.
$217
UCB, Inc.
$213
Arcutis Biotherapeutics, Inc.
$188
NOBELPHARMA AMERICA, LLC
$162
Aclaris Therapeutics, Inc.
$142
Genentech USA, Inc.
$141
Boehringer Ingelheim Pharmaceuticals, Inc.
$127
Mayne Pharma Inc.
$125
Promius Pharma LLC
$125
Taro Pharmaceuticals USA, Inc.
$124
AstraZeneca Pharmaceuticals LP
$120
Amgen Inc.
$109
Fresenius Kabi USA, LLC
$71
Almirall LLC
$54
VYNE Pharmaceuticals Inc.
$53
Biofrontera Inc.
$51
Mylan Pharmaceuticals Inc.
$49
Celgene Corporation
$46
Kerecis Limited
$27
EPI Health, LLC
$25
TARO PHARMACEUTICALS USA, INC.
$25
REVANCE THERAPEUTICS, INC.
$24
Octapharma USA, Inc.
$20
Kyowa Kirin, Inc.
$18
Sandoz Inc.
$18
STRATA Skin Sciences, Inc.
$17
Medimetriks Pharmaceuticals, Inc.
$15
KCI USA, Inc
$14
Top 3 companies account for 55.8% of total payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · ESKATA · EUCRISA · Enbrel · Erivedge · FASENRA · FILSUVEZ · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HEMANGEOL · HUMIRA · HYFTOR · Humira · IDACIO · ILUMYA · Ilumya · JUBLIA · KERYDIN · Kerecis Omega3 SurgiClose · LIBTAYO · Neo-Synalar · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO (sonidegib) capsules · OLUMIANT · OPZELURA · ORACEA · Odomzo · Olux · Otezla · POTELIGEO · QBREXZA · REMICADE · RHOFADE · RINVOQ · Rituxan · SILVERCEL · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TAPINAROF · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TRI-LUMA · Tremfya · Trianex · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VTAMA · VYJUVEK · Veltin · Winlevi · XTRAC · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (73%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pediatric dermatology physician and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $1,438 per 100 Medicare services performed
Looking for a pediatric dermatology physician in San Antonio?
Compare pediatric dermatology physicians in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse pediatric dermatology physicians nearby

Geographic Context

Pediatric Dermatology Physicians within 10 mi
2
Per 100K population
0.1
County median income
$70,571
Nearest hospital
Brooke Army Medical Center (FT Sam Houston)
3.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Browning is a mixed practice specialist, with above-average Medicare volume (top 9% in TX), and high industry engagement (speaking/promotional, top 12%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Browning experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Browning performed 11,200 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Browning receive payments from pharmaceutical companies?
Yes. Dr. Browning received a total of $277,826 from 52 companies across 1,000 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Browning's costs compare to other pediatric dermatology physicians in San Antonio?
Dr. Browning's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Browning) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →